IMPORTANT DISCLAIMER: Blank Capital Research ("BCR") is a technology platform, not a registered investment advisor or broker-dealer. The algorithmically generated signals, scores, and rankings provided on this site ("God Mode" Signals) are for informational and research purposes only and do not constitute financial advice, investment recommendations, or an offer to sell or solicit an offer to buy any securities.
HYPOTHETICAL PERFORMANCE RESULTS: The "timing scores" and "regime signals" displayed are based on quantitative models. Hypothetical or simulated performance results have certain inherent limitations. Unlike an actual performance record, simulated results do not represent actual trading. Also, since the trades have not actually been executed, the results may have under-or-over compensated for the impact, if any, of certain market factors, such as lack of liquidity.
RISK OF LOSS: Trading in financial markets involves a high degree of risk and may result in the loss of your entire investment. Data provided by third-party sources (Intrinio, Snowflake) is believed to be reliable but is not guaranteed for accuracy or completeness. Past performance is not indicative of future results.
© 2026 Blank Capital Research. All rights reserved. System Version: Aegis V8 (God Mode).
Significant upside volume detected in AFCG. Positive sentiment following recent fundamental momentum.
AFC Gamma, Inc. originates, structures, underwrites, and invests in senior secured loans, and other types of loans and debt securities for established companies operating in the cannabis industry in states that have legalized medicinal and/or adult use cannabis. The company was incorporated in 2020 and is based in West Palm Beach, Florida.
Finance, Insurance, And Real Estate
Real Estate
$86.54M
Leonard M. Tannenbaum
Get full access to institutional-quality research tools with Blank Capital Pro.
Upgrade to ProStarting at $19.99/mo
Get full access to institutional-quality research tools with Blank Capital Pro.
Upgrade to ProStarting at $19.99/mo
High yield may not be sustainable given weak profitability.
Get full access to institutional-quality research tools with Blank Capital Pro.
Upgrade to ProStarting at $19.99/mo
Get full access to institutional-quality research tools with Blank Capital Pro.
Upgrade to ProStarting at $19.99/mo
Get full access to institutional-quality research tools with Blank Capital Pro.
Upgrade to ProStarting at $19.99/mo
X-AXIS: EV/EBITDA (LOWER = CHEAPER) | Y-AXIS: ROE (HIGHER = ELITE) | RED CIRCLE = AFCG ANALYSIS TARGET
| Stock | Rating | Score▼ | Quality | Value | Momentum | P/E | EV/EBITDA | ROE | ROA | Gross Mgn | Op Mgn | Net Mgn | Rev Growth | Div Yield | D/E | Mkt Cap | AUDIT |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
$SII SPROTT INC. | 75 | 91 | 87 | 98 | - | - | 15.7% | 12.8% | 48.9% | 37.0% | 28.8% | 14.9% | 2.5% | 0.0x | $1.1B | VS | |
$PUK PRUDENTIAL PLC | 73 | 88 | 97 | 80 | - | - | 13.2% | 1.4% | 100.0% | 97.0% | 23.8% | 11.8% | 2.7% | 5.0x | $21.5B | VS | |
$NMR NOMURA HOLDINGS INC | 72 | 81 | 92 | 87 | - | - | 9.9% | 0.6% | 84.5% | 70.0% | 7.3% | 14.9% | 0.0% | 923.0x | $18.3B | VS | |
$PSLV Sprott Physical Silver Trust | 69 | 82 | 80 | 98 | - | - | 17.3% | 17.7% | 100.0% | 100.0% | 100.0% | 1643.8% | 0.0% | 0.0x | $5.0B | VS | |
$UFCS UNITED FIRE GROUP INC | 68 | 81 | 93 | 76 | 5.0x | 3.5x | 13.2% | 4.1% | 99.9% | 14.7% | 11.1% | 9.2% | 2.1% | 16.0x | $775M | VS | |
$SLF SUN LIFE FINANCIAL INC | 68 | 83 | 95 | 63 | - | - | 12.6% | 0.9% | 32.0% | 31.3% | 7.9% | -12.9% | 4.3% | 24.0x | $37.8B | VS | |
$CBOE Cboe Global Markets, Inc. | 68 | 75 | 63 | 77 | 21.3x | 15.7x | 24.0% | 13.7% | 41.7% | 32.4% | 26.4% | 8.2% | 1.1% | 30.0x | $25.7B | VS | |
$PHYS Sprott Physical Gold Trust | 67 | 64 | 82 | 91 | - | - | 22.5% | 22.8% | 101.8% | 100.0% | 100.0% | 138.9% | 0.0% | 0.0x | $8.4B | VS | |
$VTMX Vesta Real Estate Corporation, S.A.B. de C.V. | 67 | 69 | 77 | 80 | - | - | 8.8% | 5.8% | 98.7% | 75.7% | 88.5% | 17.6% | 4.3% | 34.0x | $2.2B | VS | |
$GLDM World Gold Trust | 66 | 54 | 85 | 92 | 11.3x | 11.3x | - | 27.1% | 100.0% | 98.9% | 459.9% | 333.4% | 0.0% | 0.0x | $43.7B | VS | |
$AFCG Advanced Flower Capital Inc. | 18 | 13 | 10 | 4 | - | 2.9x | -11.9% | -7.0% | - | 62.5% | -81.7% | -64.5% | 22.4% | 70.0x | $87M | ||
| SECTOR BENCH | - | - | - | - | - | 11.9x | 7.8x | 8.9% | 1.2% | 76.5% | 17.0% | 21.5% | 10.8% | 1.9% | 0.5x | - | REF |
Advanced Flower Capital Inc. (AFCG) receives a "Avoid" rating with a composite score of 17.9/100. It ranks #4856 out of 7,333 stocks in our coverage universe and carries a 1-star rating. Ratings are driven by a 6-factor quantitative model measuring quality, value, momentum, investment, stability, and short interest.
Sign in to join the discussion.
Leonard M. Tannenbaum
Chief Executive Officer
13
34
16
Audit Verdict: Lower quality and stability scores may indicate governance concerns.
No recent insider transactions available for AFCG
Lagging peers — losers tend to keep underperforming
Expensive relative to fundamentals — limited margin of safety
Weak fundamentals — higher risk of value trap
High volatility — wider range of outcomes increases timing risk
Aggressive spending — empire-building risk, dilutive growth
Below-average composite — caution warranted
Get full access to institutional-quality research tools with Blank Capital Pro.
Upgrade to ProStarting at $19.99/mo
Relative valuation derived from Finance, Insurance, And Real Estate sector benchmarks. Model weights: EV/EBITDA (40%), P/B (35%), P/S (25%). Re-calculated daily.
No analyst ratings for AFCG.
View All RatingsYOY expansion rate
Operating efficiency
Bottom-line conversion
Equity capital efficiency
Asset base utilization
Financial leverage load
Direct cash return
Material decline in asset turnover efficiency detected
High margin volatility — erratic forensic earnings quality
Capital Income Projection
A $10,000 capital deployment would generate approximately $2245 annually in verified dividends.
ROIC 5.6% vs WACC 4.7% (spread +1.0%)
GM N/A vs sector 77%, OM 62% vs sector 17%
Capital turnover 0.10x
Rev growth -64%, 4yr history
Interest coverage 2.3x, Net debt/EBITDA 17.7x
Composite assessment of profitability, capital efficiency, and financial strength. Top-tier entities demonstrate sustainable cash flow generation and elite competitive moats.
Profit generated per dollar of shareholder equity
Efficiency of asset utilization
Pricing power and cost efficiency
Core business profitability
Bottom-line profitability
The Quality factor evaluates the persistence and magnitude of realized cash flows. Companies with scores >70 exhibit superior pricing power and structural financial resilience through diverse economic regimes.
Our uncertainty rating tracks the predictability of future cash flows and potential for permanent capital loss. Moderate visibility with standard industry cyclicality.
Our quantitative model flags Advanced Flower Capital Inc. with an Avoid rating, assigning a composite score of 17.9/100 and 1 out of 5 stars. Ranked #4856 of 7,333 stocks, AFCG falls in the bottom tier across key factors. Historically, stocks with this profile have faced elevated risk of underperformance and capital loss.
Advanced Flower Capital Inc. registers a weak quality score of just 13/100, indicating significant profitability challenges. The company reports a return on equity of -11.9% (sector avg: 8.9%), net margins of -81.7% (sector avg: 21.5%). Low quality scores are often associated with businesses in turnaround mode, early-stage growth, or structurally challenged industries.
AFCG registers a value score of just 10/100, suggesting the stock trades at a significant premium to its fundamental metrics. Key valuation metrics include an EV/EBITDA of 2.85x, a P/B ratio of 0.30x. High-premium valuations like this require strong future execution to avoid multiple compression, and downside risk is elevated if growth disappoints.
Advanced Flower Capital Inc.'s investment score of 34/100 suggests limited reinvestment activity. Key growth metrics include revenue growth of -64.5% vs. a sector average of 10.8% and a return on assets of -7.0% (sector: 1.2%). While this can be positive for mature, cash-generative businesses returning capital to shareholders, it may also signal a lack of growth opportunities or management conservatism.
Advanced Flower Capital Inc. is experiencing notably weak momentum with a score of just 4/100. The stock has underperformed its peers and is trending below major moving averages. Revenue growth stands at -64.5% year-over-year, while a beta of 1.35 reflects its sensitivity to broader market moves. While deep momentum weakness can occasionally present value opportunities, it often reflects deteriorating fundamentals or structural headwinds that may persist.
Advanced Flower Capital Inc. registers a low stability score of 16/100, indicating high volatility and potentially stressed financial conditions. Key stability metrics include a beta of 1.35 and a debt-to-equity ratio of 70.00x (sector avg: 0.5x). Stocks at this level carry elevated capital loss risk and may be unsuitable for conservative portfolios without careful risk management.
Advanced Flower Capital Inc.'s short interest score of 16/100 reveals significant bearish positioning, suggesting institutional investors are actively betting against the stock. Specific risk factors include above-average market sensitivity (beta: 1.35), elevated leverage (D/E: 70.00x), micro-cap liquidity risk. At $87M (micro-cap), AFCG carries meaningful risk and is best suited for investors with high risk tolerance who have thoroughly evaluated the bear thesis.
Advanced Flower Capital Inc. offers an attractive dividend yield of 22.4%, placing it among the higher-yielding stocks in its peer group. This compares to a sector average dividend yield of 1.9%. A yield this high can provide meaningful income, but investors should verify the payout is sustainable by examining the payout ratio, free cash flow coverage, and any history of dividend cuts.
Advanced Flower Capital Inc. is a micro-cap company in the Finance, Insurance, And Real Estate sector, ranked #0 of 50 in its sector (100th percentile) and #4856 of 7,333 overall (34th percentile). Key comparisons include ROE of -11.9% trailing the 8.9% sector median and operating margins of 62.5% above the 17.0% sector average. This top-quartile standing reflects exceptional competitive strength relative to Finance, Insurance, And Real Estate peers.
While AFCG currently exhibits a AVOID profile, superior opportunities exist within the FINANCE, INSURANCE, AND REAL ESTATE sector. Our model identifies several "Strong Buy" candidates with higher quality scores and more attractive valuations among direct industry competitors.
View Top Finance, Insurance, And Real Estate Alpha →Quant Factor Profile
Upgrade catalyst
Improvement in Momentum (4) would have the largest impact on the composite score.
EV/EBITDA 63% BELOW SECTOR MEDIAN (FAVORABLE)
ROE 234% BELOW SECTOR MEDIAN
Op. Margin 267% ABOVE SECTOR MEDIAN (FAVORABLE)
AUDIT DATA AS OF SEP 30, 2025 (Q2 FY2025)
We rate Advanced Flower Capital Inc. (AFCG) as Avoid with a composite score of 17.9/100 at a current price of $2.32. The stock falls in the bottom quintile of our universe across key quantitative factors, and the multi-factor weakness suggests a high probability of continued underperformance.
The rating is primarily driven by strength in investment (34th percentile) and stability (16th percentile), which together account for the majority of the composite score. Offsetting weakness in momentum (4th percentile) and value (10th percentile) tempers our overall conviction. We assign a No Moat rating (26/100), Very High uncertainty, and Poor capital allocation.
Key items to watch: momentum to confirm whether the current price trend has legs; the path to profitability; valuation compression risk if growth disappoints. Any material change in these dynamics could warrant a reassessment of our rating. The moat trend is stable, which suggests the competitive landscape is stable for now.
Advanced Flower Capital Inc. holds a top-quartile position (#0 of 50) within the Finance, Insurance, And Real Estate sector, based on our composite quantitative scoring across quality, value, momentum, and stability factors. The composite score of 17.9/100 places it at rank #4856 in our full 7,333-stock universe. At $87M in market capitalization, Advanced Flower Capital Inc. is a small-cap player in the Finance, Insurance, And Real Estate space, which limits certain scale advantages but may allow for more agile strategic execution.
Revenue contraction of -64% combined with momentum at the 4th percentile paints a cautious picture of the near-term business outlook. The market appears to be pricing in continued challenges, and a catalyst for reversal is not clearly visible from current data.
Available margin data shows operating margins of 62%. Incomplete margin data limits our ability to fully assess the cost structure and margin trajectory, though the available metrics provide a partial view of operating efficiency.
At a current price of $2.32, Advanced Flower Capital Inc. is trading at a premium to fundamental value. Our value factor score of 10/100 reflects a composite assessment across multiple valuation metrics including price-to-earnings, price-to-book, EV/EBITDA, and price-to-sales ratios relative to both sector peers and the broader market. The premium valuation implies the market is pricing in significant future growth or quality improvements that are not yet fully reflected in current fundamentals.
The stock currently trades at EV/EBITDA of 2.9x (discounted to peers), P/B of 0.3x, P/S of 1.8x. We evaluate these multiples in the context of both absolute levels and sector-relative positioning to form our valuation view.
A 22.45% dividend yield provides income while you wait, and dividends historically account for a significant portion of total equity returns.
The Avoid rating (composite 17.9/100) reflects multi-factor weakness, and historically, stocks in this scoring range have underperformed the market by a meaningful margin.
Revenue decline of -64% signals business deterioration — declining revenues make it difficult to grow into the current valuation and often precede further negative revisions.
Thin net margins of -81.7% provide limited cushion against cost pressures, competitive pricing, or macroeconomic headwinds — even small changes in costs could swing the company to a loss.
Weak momentum (4th percentile) suggests institutional selling pressure and unfavorable technical dynamics that may persist.
We assign a Very High uncertainty rating to Advanced Flower Capital Inc.. The stock exhibits multiple compounding risk factors: elevated market sensitivity (beta of 1.35), current negative profitability (net margin -81.7%), below-average price stability (16th percentile). The extreme uncertainty around future cash flows makes precise valuation difficult, and the range of outcomes is exceptionally wide. Only investors with high risk tolerance and extended time horizons should consider this name.
Specific risk factors that inform our assessment include: elevated market sensitivity (beta of 1.35); current negative profitability (net margin -81.7%); below-average price stability (16th percentile); weak quality scores (13th percentile). Each of these factors independently widens the distribution of potential outcomes, and in combination they create a risk profile that demands careful position sizing. The stability factor at the 16th percentile and quality factor at the 13th percentile provide a quantitative summary of the overall risk landscape.
Key risk mitigants include: a 22.45% dividend yield anchors total return. These factors partially offset the identified risks and provide downside protection in adverse scenarios. On balance, the risk-reward profile warrants caution and disciplined position management.
We rate Advanced Flower Capital Inc.'s capital allocation as Poor. Key concerns include low returns on equity (-11.9%), negative profitability, weak asset returns (ROA -7.0%). Exemplary capital allocators generate ROE above 20% and maintain conservative leverage — Advanced Flower Capital Inc. significantly underperforms these benchmarks, raising questions about management's ability to create shareholder value.
Investors should scrutinize management's reinvestment decisions and balance sheet trajectory before committing capital. Poor capital allocation often compounds over time: overlevered balance sheets limit strategic flexibility, while low returns on capital destroy shareholder value. We would need to see sustained improvement in profitability metrics and balance sheet discipline before considering an upgrade.
In summary, Advanced Flower Capital Inc. receives a Avoid rating with a composite score of 17.9/100 (rank #4856 of 7,333). Our quantitative framework assigns a No Moat (26/100, trend: stable), Very High uncertainty, and Poor capital allocation. The average factor score across quality, value, momentum, stability, and investment is 15/100.
Our analysis does not support a constructive view on Advanced Flower Capital Inc. at this time. The combination of limited competitive advantages, very high uncertainty, and poor capital allocation suggests unfavorable risk-reward at current levels. We recommend investors avoid new positions and existing holders consider reducing exposure.
Analysis derived from Blank Capital Research quantitative terminal. For informational purposes only. No trade solicitation. Past performance not indicative of future results. Consult a qualified advisor.
We do not assign Advanced Flower Capital Inc. a meaningful economic moat, scoring 26/100 on our composite assessment. The ROIC-WACC spread of +1.0% is the primary signal of economic value creation. Current fundamentals do not demonstrate the kind of durable competitive advantages — such as superior returns on invested capital, margin superiority, or reinvestment efficiency — that would protect the company from competitive erosion over the long term. The highest-scoring pillar, margin superiority, reached only 13.5/20.
The strongest moat sources are margin superiority (13.5/20) and economic value creation (5/20). GM N/A vs sector 77%, OM 62% vs sector 17%. ROIC 5.6% vs WACC 4.7% (spread +1.0%). These pillars form the core of Advanced Flower Capital Inc.'s competitive identity and are the primary drivers of excess returns in our framework.
Areas of relative weakness include reinvestment efficiency (0/20) and growth durability (3.5/20). Capital turnover 0.10x. Improvement in these areas could meaningfully widen the moat over time, while deterioration would be an early warning of competitive erosion.
Our moat trend assessment is Stable. Multi-year ROIC and operating margin trajectories show neither meaningful improvement nor deterioration, suggesting the competitive position is steady. We expect Advanced Flower Capital Inc.'s moat profile to remain largely unchanged absent a material shift in return on capital or industry dynamics.
Key profit drivers include operating margins of 62% reflecting effective cost management, declining revenues (-64%) that pressure the earnings outlook. Our analysis indicates that profit quality raises some durability concerns, with the quality factor at the 13th percentile.
The margin profile shows operating margins of 62%, net margins of -81.7%. Return metrics include ROE of -11.9% and ROA of -7.0%. Relative to the Finance, Insurance, And Real Estate sector, sector comparison data is limited, and ROE of -11.9% compares to a sector median of 8.9%.
The balance sheet reflects moderate leverage with D/E of 70%, a dividend yield of 22.45%, revenue growth of -64%. The sector median D/E is 0%, putting Advanced Flower Capital Inc. at higher leverage than the typical peer. Overall balance sheet health is adequate for the current business environment.
Below-average quality (13th percentile) raises durability concerns about the fundamental profile and increases the risk of negative earnings surprises.
AFC Gamma, Inc. has reached a new 52-week low of USD 2.52, down significantly from its 52-week high of USD 9.93, reflecting a 69.43% stock price drop over the past year. The company has reported negative financial results for three consecutive quarters, including a decrease in net sales and low operating cash flow, with a current market capitalization of USD 103 million. These struggles are evident in its negative return on equity and its underperformance compared to the S&P 500.
Standard Wellness Holdings, a Cleveland-based multistate cannabis company, has secured a $14 million senior secured credit facility from Advanced Flower Capital Inc. This financing will be used to pay off existing debt from Focus Growth Capital Partners and a seller note with Columbia Care, and to support the acquisition of a new dispensary in St. Louis. The deal, which features a 12.5% interest rate, signifies the company's growth and financial management, especially given the challenges of financing in the cannabis industry.
AFC Gamma, Inc. (AFCG) reported its Q3 2024 earnings, highlighting a strong quarter with $59 million in new loan originations, exceeding its annual target with $116 million year-to-date. The company, now a pure-play cannabis mortgage REIT after a spin-off, discussed its strategy to capitalize on limited access to capital in the cannabis sector, anticipating slower federal reform, and maintaining a diversified portfolio with an 18% weighted average yield to maturity. Executives expressed confidence in their ability to deploy capital into quality credits despite market choppiness and an expected prolonged stagnation period for certain cannabis markets.
AFC Gamma, Inc. (NASDAQ: AFCG) announced a quarterly dividend of $0.48 per outstanding share of common stock for the quarter ending December 31, 2023. The dividend is payable on January 12, 2024, to stockholders of record on December 31, 2023, and is consistent with the previous quarter's dividend. AFC Gamma is an institutional lender specializing in loans secured by commercial real estate, including cannabis operators.
AFC Gamma, Inc. has expanded its senior credit facility to Devi Holdings Inc., operating as Nature’s Medicines, by an additional $30 million, increasing the total commitment to $62.5 million. This funding aims to support Nature’s Medicines' strategic acquisitions and business expansion across its multi-state operations. The move highlights AFC Gamma's strategy of fostering long-term relationships with growing cannabis businesses.
Above 50MA
37.18%
Net New Highs
+51081